These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 18177474)

  • 21. DNA-repair and carcinogen-metabolising enzymes genetic polymorphisms as an independent risk factor for hepatocellular carcinoma in Caucasian liver-transplanted patients.
    Borentain P; Gérolami V; Ananian P; Garcia S; Noundou A; Botta-Fridlund D; Le Treut YP; Bergé-Lefranc JL; Gérolami R
    Eur J Cancer; 2007 Nov; 43(17):2479-86. PubMed ID: 17870518
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interleukin-6 polymorphisms and gender: relationship with the occurrence of hepatocellular carcinoma in patients with end-stage liver disease.
    Falleti E; Fabris C; Toniutto P; Fontanini E; Cussigh A; Bitetto D; Fumolo E; Fornasiere E; Bragagnini W; Pinato DJ; Minisini R; Pirisi M
    Oncology; 2009; 77(5):304-13. PubMed ID: 19940521
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Matrix metalloproteinase-9 polymorphisms and renal cell carcinoma in a Japanese population.
    Awakura Y; Ito N; Nakamura E; Takahashi T; Kotani H; Mikami Y; Manabe T; Kamoto T; Habuchi T; Ogawa O
    Cancer Lett; 2006 Sep; 241(1):59-63. PubMed ID: 16466849
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Matrix metalloproteinase-1 (-1607) 1G/2G and -9 (-1562) C/T promoter polymorphisms: susceptibility and prognostic implications in nasopharyngeal carcinomas.
    Nasr HB; Mestiri S; Chahed K; Bouaouina N; Gabbouj S; Jalbout M; Chouchane L
    Clin Chim Acta; 2007 Sep; 384(1-2):57-63. PubMed ID: 17599818
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Liver transplantation for hepatocellular carcinoma under calcineurin inhibitors: reassessment of risk factors for tumor recurrence.
    Vivarelli M; Cucchetti A; La Barba G; Ravaioli M; Del Gaudio M; Lauro A; Grazi GL; Pinna AD
    Ann Surg; 2008 Nov; 248(5):857-62. PubMed ID: 18948815
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The association between the survivin -31G/C promoter polymorphism and hepatocellular carcinoma risk in a Turkish population.
    Bayram S; Akkız H; Bekar A; Akgöllü E
    Cancer Epidemiol; 2011 Dec; 35(6):555-9. PubMed ID: 21296634
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association of single nucleotide polymorphisms in promoter of matrix metalloproteinase-2, 8 genes with bladder cancer risk in Northern India.
    Srivastava P; Kapoor R; Mittal RD
    Urol Oncol; 2013 Feb; 31(2):247-54. PubMed ID: 21784671
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MTHFR C677T polymorphism and risk of HCC in patients with liver cirrhosis: role of male gender and alcohol consumption.
    Fabris C; Toniutto P; Falleti E; Fontanini E; Cussigh A; Bitetto D; Fornasiere E; Fumolo E; Avellini C; Minisini R; Pirisi M
    Alcohol Clin Exp Res; 2009 Jan; 33(1):102-7. PubMed ID: 18945219
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Donor one‑carbon metabolism gene single nucleotide polymorphisms predict the susceptibility of cancer recurrence after liver transplantation.
    Wang C; Lu D; Ling Q; Chen J; Liu Z; Guo H; Xu X; Zheng S
    Gene; 2019 Mar; 689():97-101. PubMed ID: 30529095
    [TBL] [Abstract][Full Text] [Related]  

  • 30. E-cadherin promoter polymorphism (C-160A) and risk of recurrence in patients with superficial bladder cancer.
    Lin J; Dinney CP; Grossman HB; Jhamb M; Zhu Y; Spitz MR; Wu X
    Clin Genet; 2006 Sep; 70(3):240-5. PubMed ID: 16922727
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interaction between cytochrome P450 1A2 genetic polymorphism and cigarette smoking on the risk of hepatocellular carcinoma in a Japanese population.
    Imaizumi T; Higaki Y; Hara M; Sakamoto T; Horita M; Mizuta T; Eguchi Y; Yasutake T; Ozaki I; Yamamoto K; Onohara S; Kawazoe S; Shigematsu H; Koizumi S; Kudo S; Tanaka K
    Carcinogenesis; 2009 Oct; 30(10):1729-34. PubMed ID: 19643819
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Promoter hypermethylation of the p16 gene is associated with poor prognosis in recurrent early-stage hepatocellular carcinoma.
    Ko E; Kim Y; Kim SJ; Joh JW; Song S; Park CK; Park J; Kim DH
    Cancer Epidemiol Biomarkers Prev; 2008 Sep; 17(9):2260-7. PubMed ID: 18723830
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Genetic polymorphism of UDP-glucuronosyltransferase 1F and susceptibility to hepatocellular carcinoma].
    Liu C; Bian J; Jiang F; Shen F
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2002 Aug; 19(4):324-8. PubMed ID: 12170472
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A functional polymorphism in the miR-146a gene is associated with the risk for hepatocellular carcinoma.
    Xu T; Zhu Y; Wei QK; Yuan Y; Zhou F; Ge YY; Yang JR; Su H; Zhuang SM
    Carcinogenesis; 2008 Nov; 29(11):2126-31. PubMed ID: 18711148
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Functional polymorphisms in the promoters of MMP-1, MMP-2, MMP-3, MMP-9, MMP-12 and MMP-13 are not associated with hepatocellular carcinoma risk.
    Zhai Y; Qiu W; Dong XJ; Zhang XM; Xie WM; Zhang HX; Yuan XY; Zhou GQ; He FC
    Gut; 2007 Mar; 56(3):445-7. PubMed ID: 17339256
    [No Abstract]   [Full Text] [Related]  

  • 36. Matrix metalloproteinase-9 and matrix metalloproteinase-2 gene polymorphisms in multiple sclerosis.
    Benesová Y; Vasků A; Stourac P; Hladíková M; Beránek M; Kadanka Z; Novotná H; Bednarík J
    J Neuroimmunol; 2008 Dec; 205(1-2):105-9. PubMed ID: 18835646
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genetic polymorphism in the manganese superoxide dismutase gene is associated with an increased risk for hepatocellular carcinoma in HCV-infected Moroccan patients.
    Ezzikouri S; El Feydi AE; Chafik A; Afifi R; El Kihal L; Benazzouz M; Hassar M; Pineau P; Benjelloun S
    Mutat Res; 2008 Jan; 649(1-2):1-6. PubMed ID: 18023606
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecular prediction of early recurrence after resection of hepatocellular carcinoma.
    Yoshioka S; Takemasa I; Nagano H; Kittaka N; Noda T; Wada H; Kobayashi S; Marubashi S; Takeda Y; Umeshita K; Dono K; Matsubara K; Monden M
    Eur J Cancer; 2009 Mar; 45(5):881-9. PubMed ID: 19167881
    [TBL] [Abstract][Full Text] [Related]  

  • 39. HDAC10 promoter polymorphism associated with development of HCC among chronic HBV patients.
    Park BL; Kim YJ; Cheong HS; Lee SO; Han CS; Yoon JH; Park JH; Chang HS; Park CS; Lee HS; Shin HD
    Biochem Biophys Res Commun; 2007 Nov; 363(3):776-81. PubMed ID: 17892858
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Matrix metalloproteinase-9 promoter polymorphisms in Korean patients with systemic lupus erythematosus.
    Lee YJ; Woo M; Nam JH; Baek J; Im CH; Lee EY; Lee EB; Park KS; Song YW
    Hum Immunol; 2008 Jun; 69(6):374-9. PubMed ID: 18571010
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.